Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex
about
Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brainNeurogenetics and pharmacology of learning, motivation, and cognitionThe neuropsychopharmacology of fronto-executive function: monoaminergic modulationCNTRICS final task selection: executive controlHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorderThe neurodevelopmental hypothesis of schizophrenia, revisitedGenetic triple dissociation reveals multiple roles for dopamine in reinforcement learningGenetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognitionEffect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI StudiesImpulsive delayed reward discounting as a genetically-influenced target for drug abuse prevention: a critical evaluationThe neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition.Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphismA transposon in Comt generates mRNA variants and causes widespread expression and behavioral differences among micePolymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetesModulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibitionSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceAssessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.Generation and characterization of humanized mice carrying COMT158 Met/Val alleles.Both the COMT Val158Met single-nucleotide polymorphism and sex-dependent differences influence response inhibition.Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.Differential Genetic and Epigenetic Regulation of catechol-O-methyltransferase is Associated with Impaired Fear Inhibition in Posttraumatic Stress Disorder.Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains.Genetics of emotion.A B2 SINE insertion in the Comt1 gene (Comt1(B2i)) results in an overexpressing, behavior modifying allele present in classical inbred mouse strainsGenetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in miceSchizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapiesUsing the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophreniaShifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications.Association between catechol-O-methyltrasferase Val108/158Met genotype and prefrontal hemodynamic response in schizophreniaOld dog, new tricks: the attentional set-shifting test as a novel cognitive behavioral task after controlled cortical impact injury.Theranostic Biomarkers for SchizophreniaA Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.Neurobehavioral evidence for changes in dopamine system activity during adolescence.Reduced susceptibility to confirmation bias in schizophreniaEffects of age, genes, and pulse pressure on executive functions in healthy adultsCOMT genotype affects prefrontal white matter pathways in children and adolescents.Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortexModeling deficits in attention, inhibition, and flexibility in HAND.Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers
P2860
Q24534089-EA0BFABD-49CE-4755-A31A-95CB209A4524Q24602643-BF0C36AA-F2B0-4257-94B1-9D6C6F9233A7Q24629562-7A006F32-3475-4037-80CB-E84555C2780EQ24651882-7ACFE424-7A6B-4A27-9D96-9B8521C180F3Q24652360-E8AB429B-2C85-4E72-B87F-A1060F65962FQ24658343-ABE90650-4224-416C-9019-E5F2F411E124Q24674131-C27FBDBC-8EA9-4037-9374-423070BD6394Q24681770-A9004480-4083-4F74-ABDC-0D90A9BDD68AQ26744718-518136F8-0EA9-4FA9-8739-88C17B2C21D5Q26782950-D2CB1796-CE8A-4131-9713-9E94DCDCC81BQ27013979-0C7A28BE-03F8-4F70-A0EC-1693B87E06FAQ28282922-BD4AC187-6BCB-46B3-8E4B-84251577E04CQ28475164-14BA31C2-881A-491A-B71A-101AD8D37E19Q28475961-4B3711D5-B14C-45EE-9F33-10B30E5F0D18Q28580165-6F857567-2876-4733-99F0-4E065EFCCBD4Q29618819-1E06EC9F-978F-4795-B3A3-1E6D6E992490Q30374178-ABE80A58-DC54-4AB9-90B4-7C447BBF5AB6Q30407994-755FBB73-9BEF-4028-A77D-0220C07D56A6Q30409993-A175D6C2-0546-4A35-B983-CA505E69F358Q30416883-E562EDBB-06AD-4C77-B4B5-145524506B41Q30429540-402CC900-F41D-45D4-BD5E-C0926789D010Q30439281-39481403-6D69-40DB-80BA-2555591FD1CEQ30464322-F6F2EFE4-8BCF-4F7C-AB0A-D2351FB8AC9CQ30476995-FBC87756-61A0-40D8-81DE-AE7AFDEEAD70Q30483916-580653F9-4DD8-4630-807B-1CC630BF5F00Q30484459-0D656B9C-4662-40EC-B4E6-2833B2F5C59CQ30489404-9E36441E-1BD8-4DC0-9D57-15374E1E530AQ30578267-9A81C016-497E-48DF-AB09-DAC8348BE4C3Q33281324-7B498868-F569-43C6-8CAF-5DBD0D5789A9Q33441368-76CB695F-7868-4951-917F-483B8FED7AC7Q33576385-C2A98A41-A69B-42D7-96F8-67B7EE1C5D6FQ33624412-F024FAAA-65BA-400B-8227-06A2C2C99BFEQ33624417-38D86573-32A3-4399-89ED-6F19778FD8E4Q33753341-42B73C1E-96EB-49BD-8216-8EC5574C04F4Q33818756-F8FB7DAD-8914-4E44-8484-E5A2B5D11B0CQ33939121-1A5579D0-74AB-4526-A4BF-B187F70DBB0EQ33987396-17A53913-8E34-4D18-AC0D-13A2C13682AFQ34020868-F1EB3900-F493-4AAD-A277-374BAAF987A5Q34034134-0F2C1734-C103-46BE-81AB-CA4256904ACFQ34055505-DAA8C1D4-70E0-469E-B690-B12553881EAF
P2860
Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex
description
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Juni 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/06/09)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/06/09)
@nl
наукова стаття, опублікована в червні 2004
@uk
مقالة علمية (نشرت في 9-6-2004)
@ar
name
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@ast
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@en
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@nl
type
label
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@ast
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@en
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@nl
prefLabel
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@ast
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@en
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@nl
P50
P3181
P1476
Catechol-o-methyltransferase i ...... e in the rat prefrontal cortex
@en
P2093
P J Harrison
P304
P3181
P356
10.1523/JNEUROSCI.1124-04.2004
P407
P577
2004-06-01T00:00:00Z